1H NMR derived metabolomic profile of neonatal asphyxia in umbilical cord serum: Implications for hypoxic ischemic encephalopathy

Journal of Proteome Research

Volumn 12, Issue 9, 2013, Pages 4230-4239

  Reinke, Stacey N ^a   Walsh, Brian H ^b   Boylan, Geraldine B ^b,c   Sykes, Brian D ^a   Kenny, Louise C ^c,d   Murray, Deirdre M ^b,c   Broadhurst, David I ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Neonatal Brain Research Group   (Canada)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

3 hydroxybutryate; asphyxia; cord serum; hypoxic ischemic encephalopathy; ketone; metabolomics; nuclear magnetic resonance; succinate

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETONE; ALANINE; BETAINE; CHOLINE; CREATINE; CREATININE; GLUCOSE; GLYCEROL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INOSITOL; ISOLEUCINE; KETONE; LACTIC ACID; LEUCINE; METHIONINE; O PHOSPHORYLCHOLINE; PHENYLALANINE; PHOSPHORYLCHOLINE; PYRUVIC ACID; SUCCINIC ACID; UNCLASSIFIED DRUG; VALINE;

ARTICLE; ASPHYXIA; BLOOD ANALYSIS; BRAIN INJURY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENERGY METABOLISM; FEMALE; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; METABOLISM; METABOLITE; METABOLOMICS; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERINATAL ASPHYXIA; PRIORITY JOURNAL; UMBILICAL CORD; UMBILICAL CORD BLOOD; BLOOD; CASE CONTROL STUDY; FETUS BLOOD; METABOLOME; RECEIVER OPERATING CHARACTERISTIC;

3-HYDROXYBUTYRIC ACID; ACETONE; ASPHYXIA NEONATORUM; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; GLYCEROL; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; ROC CURVE; SUCCINIC ACID;

EID: 84883781183     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400617m     Document Type: Article

References (54)

1. Locatelli, A.; Incerti, M.; Ghidini, A.; Greco, M.; Villa, E.; Paterlini, G. Factors associated with umbilical artery acidemia in term infants with low Apgar scores at 5 min Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 139 (2) 146-50
2. Volpe, J. J. Neurology of the Newborn, 4 th ed.; W.B. Saunders: Philadelphia, 2001; p 912.
3. Lawn, J. E.; Cousens, S.; Zupan, J. 4 million neonatal deaths: When? Where? Why? Lancet 2005, 365 (9462) 891-900
4. Azzopardi, D. V.; Strohm, B.; Edwards, A. D.; Dyet, L.; Halliday, H. L.; Juszczak, E.; Kapellou, O.; Levene, M.; Marlow, N.; Porter, E.; Thoresen, M.; Whitelaw, A.; Brocklehurst, P. Moderate hypothermia to treat perinatal asphyxial encephalopathy N. Engl. J. Med. 2009, 361 (14) 1349-58
5. Murray, D. M.; Ryan, C. A.; Boylan, G. B.; Fitzgerald, A. P.; Connolly, S. Prediction of seizures in asphyxiated neonates: correlation with continuous video-electroencephalographic monitoring Pediatrics 2006, 118 (1) 41-6
6. Fatemi, A.; Wilson, M. A.; Johnston, M. V. Hypoxic-ischemic encephalopathy in the term infant Clin. Perinatol. 2009, 36 (4) 835-58 vii
7. Reinke, S. N.; Hu, X.; Sykes, B. D.; Lemire, B. D. Caenorhabditis elegans diet significantly affects metabolic profile, mitochondrial DNA levels, lifespan and brood size Mol. Genet. Metab. 2010, 100 (3) 274-82
8. Szeto, S. S.; Reinke, S. N.; Sykes, B. D.; Lemire, B. D. Mutations in the Saccharomyces cerevisiae succinate dehydrogenase result in distinct metabolic phenotypes revealed through (1)H NMR-based metabolic footprinting J. Proteome Res. 2010, 9 (12) 6729-39
9. Dunn, W. B.; Broadhurst, D. I.; Atherton, H. J.; Goodacre, R.; Griffin, J. L. Systems level studies of mammalian metabolomes: The roles of mass spectrometry and nuclear magnetic resonance spectroscopy Chem. Soc. Rev. 2011, 40 (1) 387-426
10. Solberg, R.; Enot, D.; Deigner, H. P.; Koal, T.; Scholl-Burgi, S.; Saugstad, O. D.; Keller, M. Metabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigs PloS One 2010, 5 (3) e9606
11. Beckstrom, A. C.; Humston, E. M.; Snyder, L. R.; Synovec, R. E.; Juul, S. E. Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate model J. Chromatogr., A 2011, 1218 (14) 1899-906
12. Liu, J.; Litt, L.; Segal, M. R.; Kelly, M. J.; Yoshihara, H. A.; James, T. L. Outcome-related metabolomic patterns from 1H/31P NMR after mild hypothermia treatments of oxygen-glucose deprivation in a neonatal brain slice model of asphyxia J. Cereb. Blood Flow Metab. 2011, 31 (2) 547-59
13. Atzori, L.; Xanthos, T.; Barberini, L.; Antonucci, R.; Murgia, F.; Lussu, M.; Aroni, F.; Varsami, M.; Papalois, A.; Lai, A.; D'Aloja, E.; Iacovidou, N.; Fanos, V. A metabolomic approach in an experimental model of hypoxia-reoxygenation in newborn piglets: urine predicts outcome J. Matern.-Fetal Neonat. Med. 2010, 23 (Suppl 3) 134-7
14. Walsh, B. H.; Broadhurst, D. I.; Mandal, R.; Wishart, D. S.; Boylan, G. B.; Kenny, L. C.; Murray, D. M. The metabolomic profile of umbilical cord blood in neonatal hypoxic ischaemic encephalopathy PloS One 2012, 7 (12) e50520
15. Martin-Ancel, A.; Garcia-Alix, A.; Pascual-Salcedo, D.; Cabanas, F.; Valcarce, M.; Quero, J. Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations Pediatrics 1997, 100 (5) 789-94
16. Huang, C. C.; Wang, S. T.; Chang, Y. C.; Lin, K. P.; Wu, P. L. Measurement of the urinary lactate:creatinine ratio for the early identification of newborn infants at risk for hypoxic-ischemic encephalopathy N. Engl. J. Med. 1999, 341 (5) 328-35
17. Kumar, A.; Mittal, R.; Khanna, H. D.; Basu, S. Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy Pediatrics 2008, 122 (3) e722-7
18. Murray, D. M.; Boylan, G. B.; Fitzgerald, A. P.; Ryan, C. A.; Murphy, B. P.; Connolly, S. Persistent lactic acidosis in neonatal hypoxic-ischaemic encephalopathy correlates with EEG grade and electrographic seizure burden Arch. Dis. Child. 2008, 93 (3) F183-6
19. Levene, M. I.; Sands, C.; Grindulis, H.; Moore, J. R. Comparison of two methods of predicting outcome in perinatal asphyxia Lancet 1986, 1 (8472) 67-9
20. Sarnat, H. B.; Sarnat, M. S. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study Arch. Neurol. 1976, 33 (10) 696-705
21. Amiel-Tison, C. Update of the Amiel-Tison neurologic assessment for the term neonate or at 40 weeks corrected age Pediatr. Neurol. 2002, 27 (3) 196-212
22. Pressler, R. M.; Boylan, G. B.; Morton, M.; Binnie, C. D.; Rennie, J. M. Early serial EEG in hypoxic ischaemic encephalopathy Clin. Neurophysiol. 2001, 112 (1) 31-7
23. Murray, D. M.; Boylan, G. B.; Ryan, C. A.; Connolly, S. Early EEG findings in hypoxic-ischemic encephalopathy predict outcomes at 2 years Pediatrics 2009, 124 (3) e459-67
24. Kirwan, J. A.; Broadhurst, D. I.; Davidson, R. L.; Viant, M. R. Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow Anal. Bioanal. Chem. 2013, 405 (15) 5147-57
25. US FDA Bioanalytical Method Validation; US FDA: Silver Spring, MD, 2001.
26. Dunn, W. B.; Wilson, I. D.; Nicholls, A. W.; Broadhurst, D. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans Bioanalysis 2012, 4 (18) 2249-64
27. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing J. R. Stat. Soc. Ser. B, Methodol. 1995, 57 (1) 289-300
28. Krzanowski, W. J. Principles of Multivariate Analysis: A User's Perspective. Oxford University Press: Oxford, 1988; p 563.
29. Hastie, T.; Tibshirani, R.; Friedman, J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2 nd ed.; Springer: New York, 2009; p 745.
30. Peres-Neto, P. R.; Jackson, D. A.; Somers, K. M. Giving meaningful interpretation to ordination axes: Assessing loading significance in principal component analysis Ecology 2003, 84, 2347-63
31. Xia, J.; Broadhurst, D. I.; Wilson, M.; Wishart, D. S. Translational biomarker discovery in clinical metabolomics: An introductory tutorial Metabolomics 2013, 9 (2) 280-99
32. Rabinowitz, J. D.; White, E. Autophagy and metabolism Science 2010, 330 (6009) 1344-8
33. Wallace, D. C.; Lott, M. T.; Procaccio, V., Mitochondrial genes in degenerative disease, cancer, and aging. In Emery and Rimoin's Principles and Practice of Medical Genetics; Rimoin, D. L.; Connor, J. M.; Pyeritz, R. E.; Korf, B. R., Eds.; Churchill Livingstone: Birmingham, 2007; Vol. 1, pp 194-298.
34. Ward Platt, M.; Deshpande, S. Metabolic adaptation at birth Sem. Fetal Neonat. Med. 2005, 10 (4) 341-50
35. Prins, M. L. Cerebral metabolic adaptation and ketone metabolism after brain injury J. Cereb. Blood Flow Metab. 2008, 28 (1) 1-16
36. Gasior, M.; Rogawski, M. A.; Hartman, A. L. Neuroprotective and disease-modifying effects of the ketogenic diet Behav. Pharm. 2006, 17 (5-6) 431-9
37. Marie, C.; Bralet, A. M.; Gueldry, S.; Bralet, J. Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis Metab. Brain Dis. 1990, 5 (2) 65-75
38. Puchowicz, M. A.; Zechel, J. L.; Valerio, J.; Emancipator, D. S.; Xu, K.; Pundik, S.; LaManna, J. C.; Lust, W. D. Neuroprotection in diet-induced ketotic rat brain after focal ischemia J. Cereb. Blood Flow Metab. 2008, 28 (12) 1907-16
39. Prins, M. L.; Lee, S. M.; Fujima, L. S.; Hovda, D. A. Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats J. Neurochem. 2004, 90 (3) 666-72
40. Veech, R. L.; Chance, B.; Kashiwaya, Y.; Lardy, H. A.; Cahill, G. F., Jr. Ketone bodies, potential therapeutic uses IUBMB life 2001, 51 (4) 241-7
41. Bough, K. J.; Wetherington, J.; Hassel, B.; Pare, J. F.; Gawryluk, J. W.; Greene, J. G.; Shaw, R.; Smith, Y.; Geiger, J. D.; Dingledine, R. J. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet Ann. Neurol. 2006, 60 (2) 223-35
42. Suzuki, Y.; Takahashi, H.; Fukuda, M.; Hino, H.; Kobayashi, K.; Tanaka, J.; Ishii, E. Beta-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes Brain Res. 2009, 1268, 17-23
43. Sullivan, P. G.; Rippy, N. A.; Dorenbos, K.; Concepcion, R. C.; Agarwal, A. K.; Rho, J. M. The ketogenic diet increases mitochondrial uncoupling protein levels and activity Ann. Neurol. 2004, 55 (4) 576-80
44. Maalouf, M.; Sullivan, P. G.; Davis, L.; Kim, D. Y.; Rho, J. M. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation Neuroscience 2007, 145 (1) 256-64
45. Fan, X.; Heijnen, C. J.; van der Kooij, M. A.; Groenendaal, F.; van Bel, F. The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury Brain Res. Rev. 2009, 62 (1) 99-108
46. Majmundar, A. J.; Wong, W. J.; Simon, M. C. Hypoxia-inducible factors and the response to hypoxic stress Mol. Cell 2010, 40 (2) 294-309
47. Selak, M. A.; Armour, S. M.; MacKenzie, E. D.; Boulahbel, H.; Watson, D. G.; Mansfield, K. D.; Pan, Y.; Simon, M. C.; Thompson, C. B.; Gottlieb, E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase Cancer Cell 2005, 7 (1) 77-85
48. Gordan, J. D.; Thompson, C. B.; Simon, M. C. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation Cancer Cell 2007, 12 (2) 108-13
49. Papandreou, I.; Cairns, R. A.; Fontana, L.; Lim, A. L.; Denko, N. C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell metabolism 2006, 3 (3) 187-97
50. Kim, J. W.; Tchernyshyov, I.; Semenza, G. L.; Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia Cell Metab. 2006, 3 (3) 177-85
51. Higashida, T.; Kreipke, C. W.; Rafols, J. A.; Peng, C.; Schafer, S.; Schafer, P.; Ding, J. Y.; Dornbos, D., 3rd; Li, X.; Guthikonda, M.; Rossi, N. F.; Ding, Y. The role of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury J. Neurosurg. 2011, 114 (1) 92-101
52. Dang, E. V.; Barbi, J.; Yang, H. Y.; Jinasena, D.; Yu, H.; Zheng, Y.; Bordman, Z.; Fu, J.; Kim, Y.; Yen, H. R.; Luo, W.; Zeller, K.; Shimoda, L.; Topalian, S. L.; Semenza, G. L.; Dang, C. V.; Pardoll, D. M.; Pan, F. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1 Cell 2011, 146 (5) 772-84
53. Chen, W.; Jadhav, V.; Tang, J.; Zhang, J. H. HIF-1 alpha inhibition ameliorates neonatal brain damage after hypoxic-ischemic injury Acta Neurochir. Suppl. 2008, 102, 395-9
54. Kanelakis, K. C.; Palomino, H. L.; Li, L.; Wu, J.; Yan, W.; Rosen, M. D.; Rizzolio, M. C.; Trivedi, M.; Morton, M. F.; Yang, Y.; Venkatesan, H.; Rabinowitz, M. H.; Shankley, N. P.; Barrett, T. D. Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylases J. Biomol. Screening 2009, 14 (6) 627-35